Laser treatment of drusen in age-related macular Degeneration Statement and supplementary statement from the BVA, the DOG, and the RG on laser treatment of drusen in age-related macular Degeneration (AMD) (August 2017, update October 2018)Springer Link […] mehr …
Treatment of choroidal neovascularization in diseases other than neovascular age-related macular Degeneration, 2017 Statement of the BVA, the DOG, and the RG on treatment of choroidal neovascularization in diseases other than neovascular age-related macular Degeneration (October 2017) Springer Link […] mehr …
Central Serous Chorioretinopathy, 2018 Statement of the Professional Association of German Ophthalmologists (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy (January 2018) Springer Link […] mehr …
Therapeutic use of voretigene neparvovec (Luxturna TM) in ophthalmology, 2019 Statement of the DOG, the RG, and the BVA on the therapeutic use of voretigene neparvovec (Luxturna TM) in ophthalmology (January 2019) Springer Link […] mehr …
Anti-VEGF treatment in neovascular age-relatedmacular degeneration, 2020 Statement of the German Ophthalmological Society (DOG), the German Retina Society (GRS), and the Professional Associationof German Ophthalmologists (BVA) on anti-VEGF treatment in neovascular age-relatedmacular degeneration (February 2020)Springer Link […] mehr …
Anti-VEGF therapy of retinopathy of prematurity, 2020 Statement of the German Society of Ophthalmology, the German Retina Society, and the Professional Association of German Ophthalmologists on anti-VEGF therapy of retinopathy of prematurity, 2020 […] mehr …
Treatment of diabetic macular edema, 2020 Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema (October 2020) Springer Link […] mehr …